Acceleron Pharma (XLRN) Soars: Stock Up 9.8% - Tale of the Tape

By Zacks Equity Research,

Shutterstock photo

Acceleron Pharma, Inc. ( XLRN ) was a big mover last session, as its shares rose almost 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up nearly 72% in the past one-month timeframe.

In the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Acceleron currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Gentium S.p.A ( GENT ), Emergent BioSolutions, Inc. ( EBS ) and Actelion Ltd. ( ALIOF ). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>


EMERGENT BIOSOL (EBS): Free Stock Analysis Report

GENTIUM SPA-ADR (GENT): Free Stock Analysis Report

ACCELERON PHARM (XLRN): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: ALIOF , EBS , GENT , XLRN

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by